A63T (p.Ala63Thr) variant of FAT2 (Protocadherin Fat 2)
A63T (p.Ala63Thr) in FAT2 (Protocadherin Fat 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and population frequency data.
A63T (p.Ala63Thr) variant details
- p.Ala63Thr
- rs201874812
- NCI-TCGA Cosmic COSV5582
- 1000Genomes rs201874812
- ExAC rs201874812
- Variant assessed as somatic; moderate impact.
- Missense
- REVEL 0.05
- CADD 0.04
- PolyPhen-2 0.00
- SIFT 1.00
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available